BPH symptom

Related by string. BPH symptoms * bph . BPHS : benign prostatic hyperplasia BPH . Benign prostatic hyperplasia BPH . Benign Prostatic Hyperplasia BPH . benign prostatic hypertrophy BPH / SYMPTOMS . Symptoms . SYMPTOM . symp toms : urinary tract symptoms . allergy symptoms . respiratory symptoms . neurological symptoms * AUA BPH Symptom Score . BPH Symptom Score . BPH symptom score *

Related by context. Frequent words. (Click for all words.) 61 clinically meaningful improvement 60 Secondary endpoints included 60 ADAS cog 59 Secondary endpoints 59 Psoriasis Area 59 EDSS 59 neurocognitive function 58 Montgomery Asberg Depression 58 achieved statistical significance 58 dyspareunia 58 Health Assessment Questionnaire 57 QoL 57 Secondary endpoints include 57 Negative Syndrome 57 psychosocial functioning 56 Alzheimer Disease Assessment 56 PANSS 56 HRQoL 56 preoperatively 56 teriflunomide 55 analgesic efficacy 55 posttreatment 55 symptom severity 55 WOMAC 55 fasting plasma glucose FPG 55 vasomotor symptoms 55 p = .# [002] 54 erythrocyte sedimentation rate 54 Disease Activity 54 confidence interval #.#-#.# 54 carotid intima media 54 extrapyramidal symptoms 54 subscales 54 International Prostate Symptom 54 ankle brachial index 53 nonobese 53 % CI #.#-#.# [003] 53 histologic 53 creatine kinase 53 serum PSA 53 lipid parameters 53 CDAI 53 P = .# 53 UPDRS 53 biochemical recurrence 53 fasting insulin 53 HRQOL 53 myocardial perfusion 53 adenotonsillectomy 53 apolipoprotein B 53 mucosal healing 53 tertile 53 Unified Parkinson Disease 53 serum testosterone 53 coronary artery calcification 53 CK MB 52 nonfatal MI 52 Global Impression 52 histopathological 52 DAS# [002] 52 advanced adenomas 52 % CI #.#-#.# [007] 52 PsA 52 urinary symptoms 52 prespecified 52 lipid profiles 52 IPSS 51 creatinine levels 51 platelet reactivity 51 Postoperative 51 Thrombolysis 51 liver biopsies 51 MADRS 51 hemoglobin A1C 51 estimated glomerular filtration 51 Baseline characteristics 51 prolongs survival 51 ADHD RS 51 Expanded Disability Status 51 QTc prolongation 51 Prostate Specific Antigen PSA 51 left ventricular systolic 51 pharmacodynamic effects 51 erectile function 51 neuropsychological tests 50 demonstrated statistically significant 50 T2DM 50 immunohistochemical 50 abdominal ultrasound 50 immunostaining 50 ultrasonographic 50 infarct size 50 glucose homeostasis 50 statistically significant p = 50 experimentally induced 50 statistically significant p 50 hypoglycemic events 50 leukopenia 50 carotid stenosis 49 D dimer 49 mmol l

Back to home page